Mediastinoscopy-assisted esophagectomy for T2 middle and lower thoracic esophageal squamous cell carcinoma patients

被引:12
|
作者
Wang, Jun [1 ]
Wei, Ning [1 ]
Lu, Yimin [1 ]
Zhang, Xiaoying [1 ]
Jiang, Nanqing [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, 185 Juqian Rd, Changzhou 213003, Jiangsu, Peoples R China
关键词
Esophageal carcinoma; Ivor Lewis; Mediastinoscopy-assisted esophagectomy; TRANSTHORACIC ESOPHAGECTOMY; CANCER; SURGERY; EPIDEMIOLOGY; MORTALITY; CHINA;
D O I
10.1186/s12957-018-1361-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We aimed to compare mediastinoscopy-assisted esophagectomy (MAE) with the Ivor Lewis procedure in T2 middle and lower thoracic esophageal carcinoma patients in fields of perioperative complications and overall survival (OS). Methods: The clinical data of 112 T2 esophageal cancer patients who received MAE (n = 31) or Ivor Lewis procedure (n = 81) from January 2010 to December 2015 were retrospectively analyzed in propensity score analysis. Thirty-eight T2 esophageal cancer patients who underwent MAE (n = 19) and Ivor Lewis procedure (n = 19) were included in this study. The perioperative conditions and OS were analyzed. Results: The MAE group showed shorter operation time (143.2 +/- 20.6 vs 176.8 +/- 31.1 min, P = 0.001), less drainage in 24 h (119.2 +/- 235.1 vs 626.3 +/- 396.3 mL, P < 0.001), less retention time of thoracic tube (27.8 +/- 24.0 vs 101.2 +/- 54.6 h, P < 0.001), and less hemorrhage during operation (255.4 +/- 159.8 vs 367.4 +/- 150.9 mL, P = 0.059) compared with the Ivor Lewis group. Less dissected lymph nodes were detected in the MAE group (12.2 +/- 5.4 vs 16.8 +/- 5.8, P = 0.044) than in the Ivor Lewis group, especially in the upper mediastinum (1.8 +/- 2.1 vs 3.5 +/- 2.3, P < 0.001) and middle mediastinum (2.5 +/- 2.0 vs 5.3 +/- 3.2, P = 0.027). The mean survival time was 59.1 and 53.3 months for the MAE group and Ivor Lewis group, respectively (P = 0.635). The results of Cox regression indicated that the nodal stage (P = 0.016) was an independent prognostic factor and the surgical method was not an independent prognostic factor for these patients (P = 0.290). Conclusions: MAE procedure showed less surgical trauma compared with the Ivor Lewis procedure. The mediastinal lymphadenectomy of T2 esophageal carcinoma patients who underwent MAE was inferior to those who underwent Ivor Lewis procedure. The perioperative complications and OS of the MAE group were no worse than that of the Ivor Lewis group.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy
    Su, Dan
    Zhou, Xinming
    Chen, Qixun
    Jiang, Youhua
    Yang, Xun
    Zheng, Weihui
    Tao, Kaiyi
    Wu, Jie
    Yan, Zhen
    Liu, Liang
    Wu, Shaoyuan
    Mao, Weimin
    [J]. PLOS ONE, 2015, 10 (04):
  • [22] Significance of Thoracic Duct Resection During Esophagectomy for Esophageal Squamous Cell Carcinoma
    Shingo Kanaji
    [J]. Annals of Surgical Oncology, 2023, 30 : 2582 - 2583
  • [23] Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy
    Deng, Wei
    Zhang, Wencheng
    Yang, Jinsong
    Ni, Wenjie
    Yu, Shufei
    Li, Chen
    Chang, Xiao
    Zhou, Zongmei
    Chen, Dongfu
    Feng, Qinfu
    Chen, Xiaohui
    Lin, Yu
    Zhu, Kunshou
    Zheng, Xiongwei
    He, Jie
    Gao, Shugeng
    Xue, Qi
    Mao, Yousheng
    Cheng, Guiyu
    Sun, Kelin
    Liu, Xiangyang
    Fang, Dekang
    Chen, Junqiang
    Xiao, Zefen
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2890 - 2898
  • [24] Results of neoadjuvant therapy followed by esophagectomy for patients with locally advanced thoracic esophageal squamous cell carcinoma
    Lin, Dong
    Ma, Longfei
    Ye, Ting
    Pan, Yunjian
    Shao, Longlong
    Song, Zuodong
    Jiang, Shujun
    Chen, Haiquan
    Xiang, Jiaqing
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (02) : 318 - 326
  • [25] Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy
    Wei Deng
    Wencheng Zhang
    Jinsong Yang
    Wenjie Ni
    Shufei Yu
    Chen Li
    Xiao Chang
    Zongmei Zhou
    Dongfu Chen
    Qinfu Feng
    Xiaohui Chen
    Yu Lin
    Kunshou Zhu
    Xiongwei Zheng
    Jie He
    Shugeng Gao
    Qi Xue
    Yousheng Mao
    Guiyu Cheng
    Kelin Sun
    Xiangyang Liu
    Dekang Fang
    Junqiang Chen
    Zefen Xiao
    [J]. Annals of Surgical Oncology, 2019, 26 : 2890 - 2898
  • [26] Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus
    Tachibana, M
    Kinugasa, S
    Dhar, DK
    Tabara, H
    Masunaga, R
    Kotoh, T
    Kubota, H
    Nagasue, N
    [J]. ARCHIVES OF SURGERY, 1999, 134 (01) : 50 - 54
  • [27] Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis
    Liu, Chia
    Tsai, Ping-Chung
    Chien, Ling-, I
    Huang, Chien-Sheng
    Hsieh, Chih-Cheng
    Hsu, Han-Shui
    Hsu, Po-Kuei
    [J]. DISEASES OF THE ESOPHAGUS, 2024,
  • [28] Minimally invasive esophagectomy for esophageal squamous cell carcinoma in elderly patients
    Li, Yong
    Wang, Pei
    Li, Xiaohui
    Shi, Gongning
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 13007 - 13013
  • [29] Open Versus Thoracoscopic Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma
    Po-Kuei Hsu
    Chien-Sheng Huang
    Yu-Chung Wu
    Teh-Ying Chou
    Wen-Hu Hsu
    [J]. World Journal of Surgery, 2014, 38 : 402 - 409
  • [30] Selective Lymphadenectomy for Salvage Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma
    Mayanagi, Shuhei
    Haneda, Ryoma
    Inoue, Masazumi
    Ishii, Kenjiro
    Tsubosa, Yasuhiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 4863 - 4870